Exact Mass: 359.0198452
Exact Mass Matches: 359.0198452
Found 104 metabolites which its exact mass value is equals to given mass value 359.0198452,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sinigrin
C10H17NO9S2 (359.03447120000004)
Sinigrin is found in brassicas. Sinigrin is isolated from seeds of black mustard (Brassica nigra) and cabbage, as K salt. Sinigrin is present in many crucifers, major glucosinolate in Brussels sprouts (Brassica oleraceae). Sinigrin is isolated from seeds of black mustard (Brassica nigra) and cabbage, as a K salt. It is found in many crucifers, major glucosinolate in Brussels sprouts (Brassica oleraceae). Acquisition and generation of the data is financially supported in part by CREST/JST.
Florasulam
C12H8F3N5O3S (359.0299934000001)
CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7356; ORIGINAL_PRECURSOR_SCAN_NO 7353 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7334; ORIGINAL_PRECURSOR_SCAN_NO 7332 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3508; ORIGINAL_PRECURSOR_SCAN_NO 3504 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7314; ORIGINAL_PRECURSOR_SCAN_NO 7312 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7299; ORIGINAL_PRECURSOR_SCAN_NO 7295 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3579; ORIGINAL_PRECURSOR_SCAN_NO 3576 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3499; ORIGINAL_PRECURSOR_SCAN_NO 3497 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7330; ORIGINAL_PRECURSOR_SCAN_NO 7326 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7351; ORIGINAL_PRECURSOR_SCAN_NO 7349 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3513; ORIGINAL_PRECURSOR_SCAN_NO 3511 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3508; ORIGINAL_PRECURSOR_SCAN_NO 3505 CONFIDENCE standard compound; INTERNAL_ID 386; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3510; ORIGINAL_PRECURSOR_SCAN_NO 3508 INTERNAL_ID 386; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7351; ORIGINAL_PRECURSOR_SCAN_NO 7349
Flindokalner
Same as: D04192 C26170 - Protective Agent > C1509 - Neuroprotective Agent
Isoxaflutole
C15H12F3NO4S (359.04391080000005)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3488
Tiazuril
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent Coccidiostat for poultr
beta-D-Glucopyranose, 1-[N-(sulfooxy)-3-butenimidate], monopotassium salt
C10H17NO9S2 (359.03447120000004)
[(2S)-1-(4-Amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-phosphonooxyphosphinic acid
Isoxaflutole
C15H12F3NO4S (359.04391080000005)
3-(3-Chloro-4-hydroxyphenyl)imino-4-(4-nitrophenyl)pyrrolidine-2,5-dione
C16H10ClN3O5 (359.03089600000004)
3-(3-Chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione
C16H10ClN3O5 (359.03089600000004)
2-Propenyl glucosinolate
C10H17NO9S2 (359.03447120000004)
Annotation level-1
p-Chloromercuribenzoate; p-Chloromercuribenzoic acid; PCMB
2-[(4-Bromo-2-pyrrolyl)carbonylamino]-6-guanidinohexanoic acid
4S,5S,6S-manzacidin B|Manzacidin B
C12H14BrN3O5 (359.01167740000005)
2-Hydroxy-5-(1-sulfo-[2]naphthylamino)-benzoesaeure|2-hydroxy-5-(1-sulfo-[2]naphthylamino)-benzoic acid
SB 415286
C16H10ClN3O5 (359.03089600000004)
Sinigrin
C10H17NO9S2 (359.03447120000004)
An alkenylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose having a 4-[(sulfooxy)imino]but-1-en-4-yl group attached to the anomeric sulfur.
Tiazuril
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-Methyl-2-propanyl (5-bromo-2-chlorobenzyl)cyclopropylcarbamate
(5-bromo-2-phenylmethoxyphenyl)-pyrrolidin-1-ylmethanone
4-(2,4-dichlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid
C16H19Cl2NO4 (359.06910740000006)
4-((8-HYDROXY-6-SULFONAPHTHALEN-2-YL)AMINO)BENZOIC ACID
2-(4-Iodophenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
C11H11BINO4 (358.98258660000005)
2-(4-bromophenyl)-6-fluoro-3-methylquinoline-4-carboxylic acid
4-(8-Hydroxy-6-sulfonaphthalen-2-ylamino)benzoic acid
PD153035
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
tert-Butyl 3-iodo-1H-pyrrolo[2,3-b]pyridin-5-ylcarbamate
Uldazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-(3-iodophenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
C11H11BINO4 (358.98258660000005)
(4-Nitrophenyl)[2-(4-nitrophenyl)-1,3-thiazolidin-3-yl]methanone
2-BROMO-1-(5-FLUORO-6-METHYLPYRIDIN-2-YL)-2-(QUINOXALIN-6-YL)ETHANONE
3-Bromo-8-(phenylsulfonyl)-1-oxa-8-azaspiro[4.5]decane
Phenol, 4-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-, 1-(dihydrogen phosphate), sodium salt
C16H17NaO6P (359.06604120000003)
5-BROMO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE
4-(3,4-dichlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid
C16H19Cl2NO4 (359.06910740000006)
8-Amino-1-naphthol-3,6-disulfonic acid monosodium salt monohydrate
N-Methylguanosine cyclic 3,5-(hydrogen phosphate)
C11H14N5O7P (359.06308240000004)
2-(3-bromophenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
C11H11BINO4 (358.98258660000005)
3-Bromo-N,N-diethyl-5-(trifluoromethyl)benzenesulfonamide
C11H13BrF3NO2S (358.98024140000007)
3-Bromo-N-butyl-5-(trifluoromethyl)benzenesulfonamide
C11H13BrF3NO2S (358.98024140000007)
4-Bromo-N-butyl-3-(trifluoromethyl)benzenesulfonamide
C11H13BrF3NO2S (358.98024140000007)
4-Bromo-N-(tert-butyl)-3-(trifluoromethyl)benzenesulfonamide
C11H13BrF3NO2S (358.98024140000007)
3-Cyclopropyl-2-[2-(methylsulfonyl)-4-(trifluoromethyl)benzoyl]-3 -oxopropanenitrile
C15H12F3NO4S (359.04391080000005)
4-Bromo-N,N-diethyl-3-(trifluoromethyl)benzenesulfonamide
C11H13BrF3NO2S (358.98024140000007)
3-iodo-4-[(2-methylpiperidin-1-yl)methyl]benzoic acid
3-iodo-4-[(3-methylpiperidin-1-yl)methyl]benzoic acid
(3R)-3-(5-chloro-2-methoxy-phenyl)-3-fluoro-6-(trifluoromethyl)indolin-2-one
2-[(4-chlorophenyl)sulfanyl]-N-(5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl)acetamide
N-(6-fluoro-1,3-benzothiazol-2-yl)-6,7-dihydro-[1,4]dioxino[2,3-f][1,3]benzothiazol-2-amine
2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile
2-Methyladenine ribotide phosphate
C11H14N5O7P-2 (359.06308240000004)
beta-D-Glucopyranose, 1-[N-(sulfooxy)-3-butenimidate], monopotassium salt
C10H17NO9S2 (359.03447120000004)
N-[2-(5-bromo-3-pyridinyl)-1,3-benzoxazol-5-yl]butanamide
2-[[Oxo-(2,3,4,5,6-pentafluorophenyl)methyl]amino]benzoic acid ethyl ester
2-(4-Bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone
N-(5-chloro-2-methylphenyl)-4-[(4-chloro-1-pyrazolyl)methyl]benzamide
2-(2-bromo-4-chlorophenoxy)-N-cyclohexyl-N-methylacetamide
2-[2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-oxoethyl]-1,1-dioxo-1,2-benzothiazol-3-one
5-(2,5-dichlorophenyl)-N-(2,4-dimethylphenyl)-2-furancarboxamide
[4-[(3-Bromophenyl)methyl]-1-piperazinyl]-(3-pyridinyl)methanone
N-(3-bicyclo[2.2.1]heptanyl)-3-bromo-4-methoxybenzenesulfonamide
9-{2,5-anhydro-4-[(phosphonooxy)methyl]-alpha-L-lyxofuranosyl}-9H-purin-6-amine
C11H14N5O7P (359.06308240000004)
N-[(2-chloro-6-luorophenyl)methyl]-3,4-dimethoxybenzenesulonamide
C15H15ClFNO4S (359.0394312000001)
4-[(2-Chloro-4,4,4-trifluoro-3-oxobutylidene)amino]-1,5-dimethyl-2-phenylpyrazol-3-one
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] N-sulfooxybut-3-enimidothioate
C10H17NO9S2 (359.03447120000004)
Methyl 5-(2,4-dichloro-6-fluorophenoxy)-2-nitrobenzoate
Lipofermata
C15H10BrN3OS (358.97279100000003)
Lipofermata is a fatty acid transport protein 2 (FATP2) inhibitor. Lipofermata shows fatty acid transport inhibition with an IC50 of 4.84 μM in Caco-2 cells. Lipofermata, an analog of spiro-indoline-thadiazole, shows zinc-specific suppression of antibacterial activity. Lipofermata perturbs zinc homeostasis in E. coli K-12 with a MIC of 16 μM[1][2][3].
VU0422288
VU0422288 (ML396) is a positive allosteric modulator of group III mGluRs. VU0422288 inhibits mGluRs with EC50s of 125 nM, 146 nM, and 108 nM for mGluR4, mGluR7, and mGluR8, respectively in calcium mobilization assays. VU0422288 reverses deficits in contextual fear memory, social recognition, and apneas in Rett syndrome (RTT) model mice[1][2].
(2r)-2-({hydroxy[2-(3-hydroxyquinolin-2-yl)-1,3-oxazol-4-yl]methylidene}amino)-3-sulfanylpropanoic acid
(2r)-2-[(4-bromo-1h-pyrrol-2-yl)formamido]-6-carbamimidamidohexanoic acid
9-{2,7-dihydroxy-2-oxo-tetrahydro-4h-2λ⁵-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl}-2-imino-1-methyl-3h-purin-6-one
C11H14N5O7P (359.06308240000004)
2-[(4-bromo-1h-pyrrol-2-yl)formamido]-6-carbamimidamidohexanoic acid
[(z)-(1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}but-3-en-1-ylidene)amino]oxysulfonic acid
C10H17NO9S2 (359.03447120000004)
9-[(4ar,6r,7r,7as)-2,7-dihydroxy-2-oxo-tetrahydro-4h-2λ⁵-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-imino-1-methyl-3h-purin-6-one
C11H14N5O7P (359.06308240000004)
[(e)-(1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}but-3-en-1-ylidene)amino]oxysulfonic acid
C10H17NO9S2 (359.03447120000004)
3-[(3-chloro-4-hydroxyphenyl)amino]-5-hydroxy-4-(2-nitrophenyl)pyrrol-2-one
C16H10ClN3O5 (359.03089600000004)
n-[(14e)-1,1,15-trichloropentadeca-1,14-dien-3,12-diyn-8-yl]ethanimidic acid
C17H20Cl3NO (359.06104000000005)
(4s,5s,6r)-6-[(4-bromo-1h-pyrrole-2-carbonyloxy)methyl]-5-hydroxy-6-methyl-4,5-dihydro-1h-pyrimidine-4-carboxylic acid
C12H14BrN3O5 (359.01167740000005)